A Study of LY3084077 in Healthy Participants

Summary

The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3084077 in healthy participants. The study will also investigate how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study is expected to last approximately 8 weeks for each participant.

Timeline

Start

2013-05

Primary completion

2013-12

Completion

2013-12

Drugs

Indications

No indication recorded.